Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Overview of community-acquired pneumonia and the role of inflammatory mechanisms in the immunopathogenesis of severe pneumococcal disease.

Mediators of inflammation - 1 Jan 2013

Steel Helen C, Cockeran Riana, Anderson Ronald, Feldman Charles

Abstract excerpt

Community-acquired pneumonia (CAP) remains a leading cause of morbidity and mortality among the infectious diseases. Despite the implementation of national pneumococcal polyvalent vaccine-based immunisation strategies targeted at high-risk groups, Streptococcus pneumoniae (the pneumococcus) remains the most common cause of CAP. Notwithstanding the HIV pandemic, major challenges confronting the control of CAP...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biofilms
Share to Community-Acquired Infections

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cost of Illness

Share to Drug Resistance, Bacterial

Share to Inflammation

Share to Pneumonia, Bacterial

Share to Pneumonia, Pneumococcal

Share to Severity of Illness Index

Source

Open in PubMed Open full text

Identifiers

PMID: 24453422
DOI: 10.1155/2013/490346
PMCID: PMC3886318

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Overview of community-acquired pneumonia and the role of inflammatory mechanisms in the immunopathogenesis of severe pneumococcal disease.PMID 24453422Read ↗

The Global Burden of Community-Acquired Pneumonia, Encompassing Invasive Pneumococcal Disease and the Prevalence of Its Associated Cardiovascular Events, With a Focus on Pneumolysin and Macrolide Antibiotics in Pathogenesis and TherapySemantic proximity Read ↗

Molecular pathogenesis of pneumococcal pneumoniaSemantic proximity Read ↗

Immunopathogenesis, molecular phenotyping, and host-directed interventions for severe pediatric Mycoplasma pneumoniae pneumonia in the post-pandemic era.Semantic proximity Read ↗

Community-acquired pneumonia: pathophysiology and host factors with focus on possible new approaches to management of lower respiratory tract infections.Semantic proximity Read ↗

Systemic Corticosteroids in Pediatric Community-Acquired Pneumonia: Evidence, Clinical Outcomes, and Phenotype-Based Therapeutic ConsiderationsSemantic proximity Read ↗

Exploring the pathogenetic mechanisms of Mycoplasma pneumoniae (Review)Semantic proximity Read ↗

Pathogenesis of pneumococcal infectionSemantic proximity Read ↗

New Insights into the Pathogenesis and Detection of <i>Mycoplasma Pneumoniae</i> InfectionsSemantic proximity Read ↗

Pneumococcal lipoproteins involved in bacterial fitness, virulence, and immune evasionSemantic proximity Read ↗

PcpA Promotes Higher Levels of Infection and Modulates Recruitment of Myeloid-Derived Suppressor Cells during Pneumococcal Pneumonia.Semantic proximity Read ↗

The Role of Macrolide Antibiotics in the Prevention of Severe COVID-19 Disease Progression Via the Disruption of Bacteria/virus Co-OperationSemantic proximity Read ↗

Emerging concepts in the pathogenesis of theStreptococcus pneumoniae: From nasopharyngeal colonizer to intracellular pathogenSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.